Patent · US Active

Gene therapy for neurodegenerative disorders

US11911440B2 · kind B2 · utility

2Cited by
51References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2022
Grant dateFeb 27, 2024
Priority date—
Expiry dateNov 19, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treating disorders affecting motor function, such as motor function affected by disease or injury to the brain and/or spinal cord, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.